Archive - December 2004

• Winning Omnus suggestions (21/12/2004)
• Redundant cardiologists could be retrained as "polymeal" chefs and wine advisors (20/12/2004)
• Cardiovascular concerns of COX-2 inhibitors extend to celecoxib and valdecoxib (20/12/2004)
• Bristol-Myers Squibb seek OTC approval for pravastatin (20/12/2004)
• Christmas holidays may be hazardous to patients' health (17/12/2004)
• Cox-2 inhibitors differ in CV effects (17/12/2004)
• Aspirin under-used in patients with diabetes (16/12/2004)
• Calcium-channel-blocker and diuretic combination linked to higher CVD mortality (16/12/2004)
• Problem staff may be the greatest unmeasured cost to your practice - ABL News (15/12/2004)
• Uninsured NSW employers may have to stop work - ABL News (13/12/2004)
• Task force publish guidelines on fluoroscopically guided invasive cardiovascular procedures (13/12/2004)
• New risk reduction tool for docs - MO News (13/12/2004)
• Scope for further improvement in Australians' health (10/12/2004)
• Atorvastatin reduces arterial stiffness in RA (10/12/2004)
• Ten year patency of IMA graft "worse than previously thought" (10/12/2004)
• No blood glucose threshold for cardiovascular risks (10/12/2004)
• Atrial-fib catheter ablation can improve cardiac function and symptoms in HF patients (10/12/2004)
• Parents fail to recognise excess weight in children (09/12/2004)
• Fingertip test could become a useful screening tool for early CAD (09/12/2004)
• Rofecoxib: lessons learned and unanswered questions (08/12/2004)
• Can I exchange my annual holiday leave for cash? - ABL News (08/12/2004)
• Evidence linking excess weight and heart disease "consistent and statistically significant" (07/12/2004)
• Guidelines for managing alcohol in your workplace - ABL News (07/12/2004)
• Breakdown in employment relationship - ABL News (06/12/2004)
• Cardiovascular complications successfully reduced in diabetes (06/12/2004)
Displaying results 1-25 (of 32)
 |<  < 1 - 2  >  >| 

Back to archive ...